State Administration for Market Regulation, Anti-Monopoly Guidelines for the Pharmaceuticals Sector (Draft for Comments)

国家市场监督管理总局关于药品领域的反垄断指南 (征求意见稿)

SAMR prohibits monopoly agreements that fix or modify pharmaceutical prices.

2 minute readAugust 26, 2024 at 01:58 PM

Susan Mok

Issued: August 9, 2024

Main contents:Fixing or Modifying Pharmaceutical Prices

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)